Evidence map›Paper›PMID 40606199›Full record

ArticleJOR spine2025

Ultrafine-Grained Materials With Antibacterial Properties: A Novel Approach to Reducing Spinal Implant-Associated Infections.

Mitsuhiro Nishizawa, Diane Hu, Hassan Serhan, Bahram Saleh, Ralph S Marcucio, Kazuhito Morioka

Abstract read
In one paragraph

Article in JOR spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. What's New in Musculoskeletal Basic Science.The Journal of bone and joint surgery. American volume · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mitsuhiro NishizawaDepartment of Orthopaedic Surgery Orthopaedic Trauma Institute (OTI), University of California, San Francisco (UCSF) San Francisco California USA.ORCID https://orcid.org/0000-0002-9345-8939
Diane HuDepartment of Orthopaedic Surgery Orthopaedic Trauma Institute (OTI), University of California, San Francisco (UCSF) San Francisco California USA.
Hassan SerhanRosies Base. LLC Natick Massachusetts USA.
Bahram SalehRosies Base. LLC Natick Massachusetts USA.
Ralph S MarcucioDepartment of Orthopaedic Surgery Orthopaedic Trauma Institute (OTI), University of California, San Francisco (UCSF) San Francisco California USA.
Kazuhito MoriokaDepartment of Orthopaedic Surgery Orthopaedic Trauma Institute (OTI), University of California, San Francisco (UCSF) San Francisco California USA.ORCID https://orcid.org/0000-0001-5407-8178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Implant-associated infection remains a serious complication of instrumented spinal surgery. Since biofilm formation on the implant surface is a key factor in the pathogenesis of such infections, current preventive strategies include the use of implants with antibiotic coatings. However, these approaches raise concerns related to antibiotic resistance and cytotoxicity. Ultrafine-grained (UFG) stainless steel, characterized by nanoscale grain sizes, has demonstrated superior mechanical properties and potential antimicrobial effects. This study aimed to evaluate the antibacterial properties of UFG stainless steel implants against Methods: UFG and conventional SUS316L stainless steel wires were incubated with bioluminescent Results: In vitro, UFG wires had significantly lower CFU counts than standard wires at 4 h ( Conclusions: UFG stainless steel implants demonstrated a significant reduction in early biofilm formation by

Indexed as

antibacterial implantbiofilm formationimplant‐associated infectionspinal implant infectionultrafine‐grained material

Identifiers

PMID40606199
PMCPMC12208918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.